Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T20:04:57.020Z Has data issue: false hasContentIssue false
  • English
  • Français

Lamictal

Published online by Cambridge University Press:  18 September 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 23 , Issue S2 , November 1996 , pp. xxiii - xxiv
Copyright
Copyright © Canadian Neurological Sciences Federation 1996

References

1.Goa, KLel al. Lamotrigine: A review of its pharmacological properties and dinical efficacy in epilepsy. Drugs 1993;46(1):152–176.CrossRefGoogle Scholar
2.Leach, MJet al. Neurochemical and behavkxal aspects of lamotrigine. Epilepsia 1991;32(Suppl.2):S4–S8.CrossRefGoogle ScholarPubMed
3. Data on file Glaxo Wellcome (GWMN[2]:09/96).Google Scholar
4.Brodie, MJLamotrigine versus other antiepileptic drugs: A star rating system is born. Epilepsia 1994;35(Suppl.5):S41–46.Google ScholarPubMed
5.Product Monograph of LAMICTAL, Nov. 1994.Google Scholar
6.Richens, A, Yuen, AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 1991;32(Suppl.2):S13–S16.CrossRefGoogle ScholarPubMed
7.Betts, Tet al. Human safety of lamotrigine. Epilepsia 1991;32(Suppl.2):S17–S21.CrossRefGoogle ScholarPubMed
8.Binnie, CDet al. Acute effects of lamotrigine (BW 430C) in persons with epilepsy. Epilepsia 1986;27(3)248–254.CrossRefGoogle ScholarPubMed
9.Sander, JWASet alA randomised double-blind placebo-controlled add-on trial of lamtrigine in patients with severe epilepsy. Epilepsy Res 1990;6(3):221–226.CrossRefGoogle Scholar
10.Yuen, AWCLamotrigine: A review of antiepileptic efficacy. Epilepsia 1994;35(Suppl.5):S33–S3.CrossRefGoogle ScholarPubMed
11.Binne, CDLamotrigine. Comprehensive Epleptology. New York Raven Press 1990:665–670.Google Scholar
12.Binne, CDet al. Double-blind crossover tiral of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989;4(3)222–229.CrossRefGoogle Scholar
13.Dren, ATet alPlacebo-controlled, dose-response evaluation of the efficacy and safety of motrigine (LAMICTA) as add-on therapy in epileptic outpatients with partial seizures. Epilepsia 1991:32 (Suppl.3)2.Google Scholar
14.Gay, PEet al. Chronic dose tolerance of lamotrigine and placebo in patients with epilepsy. Epilepsia 1988;29(5):686.Google Scholar
15.Jawad, Set al. Controlled trial of lamotrigiie (Lamictal) for refractory partial seizures. Epilepsia 1989;30(3):356–363.CrossRefGoogle ScholarPubMed
16.Loiseau, Pet al. A randomised double-bilnd placebo-controlled crossover add-on trial of lamotrigine it patient with trealment-resistant partial seizures. Epilepsy fles 1990;7(2):136–145.CrossRefGoogle ScholarPubMed
17.Matsuo, Fet al. Placebo-controled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–2291.CrossRefGoogle ScholarPubMed
18.Messenheimer, Jet al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35(1):113–121.CrossRefGoogle ScholarPubMed
19.Mikati, MAet al. Long-term tolerability, pharmacokinetic and preliminary efficacy study of Lamotrigine in patients with resistant partial seizures. Neuropharmacol 1989;12(4):312–321.CrossRefGoogle ScholarPubMed
20.Miller, AAet al. Lamotrigine. New Anticonvulsant Drugs 1986; 165–177.Google ScholarPubMed
21.Risner, MEet al. Multicenter, double-blind, placebo-controlled, add-on, crossover study of lamotrigine (Lamictal) in epileptic outpatients with partial seizures. Epilepsia 1990;31(5):619–620.Google Scholar
22.Schapel, GJet al. No effect of lamotrigine on carbamazepine and mazepine-epoxide concentrations. Epilepsia 1991;32 (Suppl.1):58.Google Scholar
23.Smith, Det al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34(2);312–322.CrossRefGoogle ScholarPubMed
24.Betts, TClinical use of lamotrigine. Seizure 1992;1:3–6.CrossRefGoogle ScholarPubMed
25.Binnie, CD. The efficacy of lamotrigine. Rev Contemp Pharmacother 1994;5:115–122.Google Scholar
26.Cohen, AFet al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;20:619–629.CrossRefGoogle ScholarPubMed